Meningococcal Serogroup A, C, W₁₃₅ and Y Conjugated Vaccine: A Cost-Effectiveness Analysis in the Netherlands

• Hiltsje Hepkema ,

  Contributed equally to this work with: Hiltsje Hepkema, Koen B. Pouwels

  Affiliation Unit of PharmacoEpidemiology and PharmacoEconomics (PE2), Department of Pharmacy, University of Groningen, Groningen, The Netherlands

  ⨯
• Koen B. Pouwels ,

  Contributed equally to this work with: Hiltsje Hepkema, Koen B. Pouwels

  Affiliation Unit of PharmacoEpidemiology and PharmacoEconomics (PE2), Department of Pharmacy, University of Groningen, Groningen, The Netherlands

  ⨯
• Arie van der Ende,

  Affiliation Academic Medical Center, Center for Infection and Immunity Amsterdam (CINIMA), Department of Medical Microbiology and the Netherlands Reference Laboratory for Bacterial Meningitis, Amsterdam, The Netherlands

  ⨯
• Tjalke A. Westra,

  Affiliations Unit of PharmacoEpidemiology and PharmacoEconomics (PE2), Department of Pharmacy, University of Groningen, Groningen, The Netherlands, GlaxoSmithKline, Corporate Affairs, Zeist, The Netherlands

  ⨯
• Maarten J. Postma

  * E-mail: m.j.postma@rug.nl

  Affiliation Unit of PharmacoEpidemiology and PharmacoEconomics (PE2), Department of Pharmacy, University of Groningen, Groningen, The Netherlands

  ⨯